Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling
Sign Up to like & getrecommendations! Published in 2022 at "Vaccine"
DOI: 10.1101/2022.05.23.22275466
Abstract: In recent decades, there has been an increased interest in developing a vaccine for chikungunya. However, due to its unpredictable transmission, planning for a chikungunya vaccine trial is challenging. To inform decision making on the… read more here.
Keywords: trial; chikungunya vaccine; vaccine trial; endpoint events ... See more keywords